Literature DB >> 32876833

Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.

Thierry Lefebvre1,2,3, Mélanie Hébert1,2, Laurent Bilodeau1,2, Giada Sebastiani4, Milena Cerny1,2, Damien Olivié1, Zu-Hua Gao5, Marie-Pierre Sylvestre2,6, Guy Cloutier1,7,8, Bich N Nguyen9, Guillaume Gilbert1,10, An Tang11,12,13.   

Abstract

OBJECTIVE: To evaluate the diagnostic performance of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for grading hepatic inflammation.
METHODS: In this retrospective cross-sectional dual-center study, 91 patients with chronic liver disease were recruited between September 2014 and September 2018. Patients underwent 3.0-T MRI examinations within 6 weeks from a liver biopsy. IVIM parameters, perfusion fraction (f), diffusion coefficient (D), and pseudo-diffusion coefficient (D*), were estimated using a voxel-wise nonlinear regression on DWI series (10 b-values from 0 to 800 s/mm2). The reference standard was histopathological analysis of hepatic inflammation grade, steatosis grade, and fibrosis stage. Intraclass correlation coefficients (ICC), univariate and multivariate correlation analyses, and areas under receiver operating characteristic curves (AUC) were assessed.
RESULTS: Parameters f, D, and D* had ICCs of 0.860, 0.839, and 0.916, respectively. Correlations of f, D, and D* with inflammation grade were ρ = - 0.70, p < 0.0001; ρ = 0.10, p = 0.35; and ρ = - 0.27, p = 0.010, respectively. When adjusting for fibrosis and steatosis, the correlation between f and inflammation (p < 0.0001) remained, and that between f and fibrosis was also significant to a lesser extent (p = 0.002). AUCs of f, D, and D* for distinguishing inflammation grades 0 vs. ≥ 1 were 0.84, 0.53, and 0.70; ≤ 1 vs. ≥ 2 were 0.88, 0.57, and 0.60; and ≤ 2 vs. 3 were 0.86, 0.54, and 0.65, respectively.
CONCLUSION: Perfusion fraction f strongly correlated, D very weakly correlated, and D* weakly correlated with inflammation. Among all IVIM parameters, f accurately graded inflammation and showed promise as a biomarker of hepatic inflammation. KEY POINTS: • IVIM parameters derived from DWI series with 10 b-values are reproducible for liver tissue characterization. • This retrospective two-center study showed that perfusion fraction provided good diagnostic performance for distinguishing dichotomized grades of inflammation. • Fibrosis is a significant confounder on the association between inflammation and perfusion fraction.

Entities:  

Keywords:  Biopsy; Diffusion-weighted MRI; Hepatitis; Inflammation; Nonalcoholic fatty liver disease

Mesh:

Year:  2020        PMID: 32876833     DOI: 10.1007/s00330-020-07203-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  8 in total

Review 1.  Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.

Authors:  Yi Xiang J Wang; Hua Huang; Cun-Jing Zheng; Ben-Heng Xiao; Olivier Chevallier; Wei Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

2.  Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).

Authors:  Giada Sebastiani; Keyur Patel; Vlad Ratziu; Jordan J Feld; Brent A Neuschwander-Tetri; Massimo Pinzani; Salvatore Petta; Annalisa Berzigotti; Peter Metrakos; Naglaa Shoukry; Elizabeth M Brunt; An Tang; Jeremy F Cobbold; Jean-Marie Ekoe; Karen Seto; Peter Ghali; Stéphanie Chevalier; Quentin M Anstee; Heather Watson; Harpreet Bajaj; James Stone; Mark G Swain; Alnoor Ramji
Journal:  Can Liver J       Date:  2022-02-04

3.  Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging.

Authors:  Jia-Yi Liu; Ye-Yu Cai; Zhu-Yuan Ding; Zi-Yi Zhou; Min Lv; Huan Liu; Li-Yun Zheng; Lan Li; Yong-Heng Luo; En-Hua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-09-21       Impact factor: 5.119

Review 4.  Noninvasive imaging of hepatic dysfunction: A state-of-the-art review.

Authors:  Ting Duan; Han-Yu Jiang; Wen-Wu Ling; Bin Song
Journal:  World J Gastroenterol       Date:  2022-04-28       Impact factor: 5.374

5.  Computed tomography (CT) and magnetic resonance imaging (MRI) of diffuse liver disease: a multiparametric predictive modelling algorithm can aid categorization of liver parenchyma.

Authors:  Ricardo Donners; Carmen Zaugg; Julian E Gehweiler; Tuyana Boldanova; Markus H Heim; Luigi M Terracciano; Daniel T Boll
Journal:  Quant Imaging Med Surg       Date:  2022-02

Review 6.  Quantitative magnetic resonance imaging for chronic liver disease.

Authors:  Guilherme Moura Cunha; Patrick J Navin; Kathryn J Fowler; Sudhakar K Venkatesh; Richard L Ehman; Claude B Sirlin
Journal:  Br J Radiol       Date:  2021-02-26       Impact factor: 3.629

7.  Assessment of Fibrotic Liver Regeneration After Partial Hepatectomy With Intravoxel Incoherent Motion Diffusion-Weighted Imaging: An Experimental Study in a Rat Model With Carbon Tetrachloride Induced Liver Injury.

Authors:  Shuangshuang Xie; Caixin Qiu; Yajie Sun; Yongquan Yu; Zhandong Hu; Kun Zhang; Lihua Chen; Yue Cheng; Mingzhu Bao; Quansheng Zhang; Jinxia Zhu; Robert Grimm; Wen Shen
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

8.  Diffusion-Weighted Magnetic Resonance Imaging: Clinical Potential and Applications.

Authors:  Anna Caroli
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.